CaroGen Corporation

CaroGen Corporation is an emerging biopharmaceutical company with an entirely new vaccine platform technology developed at Yale University School of Medicine. The Company has recently executed an exclusive license with Yale University to the replication proficient virus-like vesicle (VLV) a platform technology for the development of vaccines for worldwide commercialization. The proprietary VLV technology which has been validated in a number of animal models including non-human primates will be employed to create new, potentially first-in-class vaccines that engage the bodys immune system to both recognize and fight off various diseases. Our vision is to control the spread of infectious diseases...

Vaccines,viral vesicles,biotherapeutics,pharmaceuticals,hepatitis b,hbv,colon cancer,immunotherapy,infectious disease,and animal health vaccine

Carogen corporation operates in the Biotechnology industry.

Carogen corporation's revenue is 1m - 10m

Carogen corporation has 11 - 50 employees.